Essure is a non-surgical, permanent birth control device that has been reported to cause women a host of adverse side effects, surgical operations, and unnecessary pain and suffering. The manufacturer, Bayer, advertised that Essure was effective and less invasive than other devices or contraceptives, therefore making the device appealing to women looking for a permanent birth control option. In 2002, the FDA approved Essure, which led to thousands of women across the country having full faith that the device was safe to be implanted. Many women who put their trust in Essure experienced a plethora of negative side effects.

Below are the reported side effects thus far;

Autoimmune responses such as:
~Fatigue
~Rashes
~Hair loss
~Weight gain
Metal poisoning
Chronic pelvic pain
Migration of the device
Expulsion of the device
Perforation of organs
Hysterectomy
Ectopic pregnancy
Fetal death

The legal battle with the manufacturer has been challenging. The device was approved through the Pre-Market Approval process, which allowed Essure to be prescribed without proper and thorough testing. Unfortunately, this Pre-Market Approval process gives the manufacturer a shield against liability. The manufacturer, however, is also accused of knowing the risks associated with the device and hiding reports of dangerous side effects women experienced. As reports of the manufacturer’s negligence continue to be reported, the shield for Bayer is looking weaker. Legal action is being taken to hold the manufacturer responsible. So far over 16,000 lawsuits have been filed against Bayer.

If you or a loved one has suffered from an Essure device, we would like to hear your story and would like to help. At our office we understand the overwhelming feelings and frustrations that a lawsuit can bring on, which is why we take the time to go over the legal process, help you fill out paperwork, and answer all questions. Call our local Long Island office at (631) 543-3663 for a free consultation. When it comes to your case, we are your point of contact.